Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Weiner

Showing results (31-40 of 339) with videos related to

Pageof 34
Sort By:
Frontiers in Immunology|March 30, 2026
Editorial: New insights in nucleic acid approaches for vaccine and biologic deliveryEbony N Gary, David B Weiner
Expert Review of Vaccines|August 3, 2004
Approaches for the design and evaluation of HIV-1 DNA vaccinesSandra A Calarota, David B Weiner
Nature|December 13, 2023
Modified messenger-RNA components alter the encoded proteinNicholas J Tursi, David B Weiner
Journal of Virology|November 9, 2007
Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business"Kimberly A Schoenly, David B Weiner
Current Opinion in Immunology|April 8, 2020
DNA vaccines: prime time is nowEbony N Gary, David B Weiner
Expert Review of Vaccines|September 5, 2008
Cancer vaccines: methods for inducing immunityVasso Apostolopoulos, David B Weiner, Jianlin Gong
Vaccine|July 19, 2011
DNA vaccines 2010: a gumbo of accomplishment and excitement in New OrleansKenneth E Ugen, Niranjan Sardesai, David B Weiner
Vaccines|May 30, 2019
Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor GrowthKrzysztof Wojtak, Alfredo Perales-Puchalt, David B Weiner
Oncotarget|November 27, 2018
Designing consensus immunogens to break tolerance to self-antigens for cancer therapyElizabeth K Duperret, Jian Yan, David B Weiner
Expert Opinion on Biological Therapy|September 15, 2010
Interferons as potential adjuvants in prophylactic vaccinesRoberta Toporovski, Matthew P Morrow, David B Weiner
Pageof 34

Showing results (31-40 of 339) with videos related to

Sort By:
Pageof 34
Frontiers in Immunology|March 30, 2026
Editorial: New insights in nucleic acid approaches for vaccine and biologic deliveryEbony N Gary, David B Weiner
Expert Review of Vaccines|August 3, 2004
Approaches for the design and evaluation of HIV-1 DNA vaccinesSandra A Calarota, David B Weiner
Nature|December 13, 2023
Modified messenger-RNA components alter the encoded proteinNicholas J Tursi, David B Weiner
Journal of Virology|November 9, 2007
Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business"Kimberly A Schoenly, David B Weiner
Current Opinion in Immunology|April 8, 2020
DNA vaccines: prime time is nowEbony N Gary, David B Weiner
Expert Review of Vaccines|September 5, 2008
Cancer vaccines: methods for inducing immunityVasso Apostolopoulos, David B Weiner, Jianlin Gong
Vaccine|July 19, 2011
DNA vaccines 2010: a gumbo of accomplishment and excitement in New OrleansKenneth E Ugen, Niranjan Sardesai, David B Weiner
Vaccines|May 30, 2019
Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor GrowthKrzysztof Wojtak, Alfredo Perales-Puchalt, David B Weiner
Oncotarget|November 27, 2018
Designing consensus immunogens to break tolerance to self-antigens for cancer therapyElizabeth K Duperret, Jian Yan, David B Weiner
Expert Opinion on Biological Therapy|September 15, 2010
Interferons as potential adjuvants in prophylactic vaccinesRoberta Toporovski, Matthew P Morrow, David B Weiner
Pageof 34